Shizuoka Children's Hospital

Shizuoka 420-8660

3 studies enrolling now · 7 studies all time

What they study most

Acute Kidney Injury, COVID, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors, Heart Block Complete, Heart Block Second Degree, Hemophilia A, Muscular Atrophy, Spinal

Studies at this site

• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block — Recruiting now
• A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes — Starting soon
• Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors — Running, not enrolling
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants — Completed
• Pediatric Acute Kidney Injury in COVID-19 — Completed
• A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors — Completed